Compare · CDXS vs LYB
CDXS vs LYB
Side-by-side comparison of Codexis Inc. (CDXS) and LyondellBasell Industries NV (LYB): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDXS and LYB operate in Major Chemicals (Industrials), so they compete in similar markets.
- LYB is the larger of the two at $20.24B, about 135.9x CDXS ($148.9M).
- LYB has been more active in the news (6 items in the past 4 weeks vs 3 for CDXS).
- LYB has more recent analyst coverage (25 ratings vs 12 for CDXS).
- Company
- Codexis Inc.
- LyondellBasell Industries NV
- Price
- -
- -
- Market cap
- $148.9M
- $20.24B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2010
- News (4w)
- 3
- 6
- Recent ratings
- 12
- 25
Codexis Inc.
Codexis, Inc. discovers, develops, and sells biocatalysts. It offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations. The company's platform is used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. Its platform also enhances the pharmaceuticals companies manufacturing productivity and efficiency or outsourcing the manufacture of the intermediates and active pharmaceutical ingredients. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
LyondellBasell Industries NV
LyondellBasell Industries N.V. operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. The company operates in six segments: Olefins and PolyolefinsÂAmericas; Olefins and PolyolefinsÂEurope, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology. It produces and markets olefins and co-products; polyolefins; polyethylene products, which consist of high density polyethylene, low density polyethylene, and linear low density polyethylene; and polypropylene (PP) products, such as PP homopolymers and copolymers. The company also produces and sells propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals, such as styrene monomers, acetyls, ethylene glycols, and ethylene oxides and derivatives. In addition, it produces and markets compounds and solutions, such as polypropylene compounds, engineered plastics, masterbatches, engineered composites, colors, and powders; and advanced polymers. Further, the company refines crude oil and other crude oils of varied types and sources into gasoline, diesel, and jet fuel; develops and licenses chemical and polyolefin process technologies; and manufactures and sells polyolefin catalysts. LyondellBasell Industries N.V. was founded in 1955 and is headquartered in Houston, Texas.
Latest CDXS
- SEC Form 4 filed by Codexis Inc.
- SEC Form 4 filed by Codexis Inc.
- Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA
- Codexis to Participate in Cantor Global Healthcare Conference 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by Codexis Inc.
- SEC Form 10-Q filed by Codexis Inc.
- Codexis Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- Codexis Reports Second Quarter 2026 Financial Results
- Codexis Appoints David Butler, PhD, to Strategic Advisory Board
- Codexis to Report Second Quarter 2026 Financial Results on August 11
Latest LYB
- SEC Form 4 filed by LyondellBasell Industries NV
- Barclays initiated coverage on LyondellBasell with a new price target
- LYB to discuss third-quarter results Friday, Oct. 30, 2026
- Director Karlin Bridget E was granted 781 units of Class A Ordinary Shares and covered exercise/tax liability with 194 units of Class A Ordinary Shares, increasing direct ownership by 8% to 7,834 units (SEC Form 4)
- Director Kamsky Virginia A was granted 720 units of Class A Ordinary Shares and covered exercise/tax liability with 139 units of Class A Ordinary Shares, increasing direct ownership by 6% to 10,864 units (SEC Form 4)
- LyondellBasell downgraded by Citigroup with a new price target
- KeyBanc Capital Markets initiated coverage on LyondellBasell
- LyondellBasell announces quarterly dividend
- Amendment: SEC Form SCHEDULE 13G/A filed by LyondellBasell Industries NV
- LyondellBasell upgraded by Analyst with a new price target